Eupraxia Pharmaceuticals Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 11, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	582	161	147	79	35	-
Market Cap Growth	277.62%	9.66%	85.89%	125.87%	-	-
Enterprise Value	501	147	127	58	10	-
Last Close Price	11.50	4.51	5.37	3.65	2.45	-
PB Ratio	4.73	3.51	124.32	8.08	1.83	-
P/TBV Ratio	7.17	65.70	50.06	7.48	1.75	-
Debt / Equity Ratio	0.00	0.00	11.71	1.25	0.52	-0.59
Quick Ratio	23.38	10.74	1.01	6.00	13.38	0.03
Current Ratio	23.98	11.10	1.02	6.08	13.49	0.05
Return on Equity (ROE)	-61.02%	-157.31%	-715.19%	-178.04%	-	-
Return on Assets (ROA)	-36.21%	-61.14%	-88.37%	-52.20%	-68.51%	-59.25%
Return on Capital Employed (ROCE)	-33.60%	-84.80%	-3120.70%	-109.70%	-61.90%	10.70%
Earnings Yield	-7.58%	-22.84%	-25.44%	-31.75%	-68.66%	-
FCF Yield	-6.04%	-26.96%	-18.77%	-25.12%	-43.73%	-
Buyback Yield / Dilution	-13.17%	-40.52%	-25.21%	-55.45%	-102.75%	-0.01%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.